Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Witzke

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Transplantation Proceedings|March 17, 2007
Results of kidney transplantation with simultaneous implantation of vascular graftA Ozçelik, J Treckmann, A Paul, et al.
Clinical and Experimental Immunology|August 2, 2006
CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosusS Patschan, S Dolff, A Kribben, et al.
Scandinavian Journal of Immunology|October 21, 2016
Humoral and Cellular Responses to a Single Dose of Fendrix in Renal Transplant Recipients with Non-response to Previous Hepatitis B VaccinationM Lindemann, M Zaslavskaya, M Fiedler, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 22, 1999
Unique alterations of thyroid function parameters after i.v. administration of alkylating drugs (cyclophosphamide and ifosfamide)W Reinhardt, V Sauter, F Jockenhövel, et al.
Transplantation|August 15, 2001
Suppression mediated by anergic CD4+ T cells requires stimulation by MHC-peptide complexes and can be induced in the presence of costimulationO Witzke, P R Wheeler, J A Barbara, et al.
Annals of the Rheumatic Diseases|February 15, 2005
Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosisB M Spriewald, O Witzke, R Wassmuth, et al.
Clinical Pharmacology and Therapeutics|December 15, 2011
Plasma noradrenaline and state anxiety levels predict placebo response in learned immunosuppressionK Ober, S Benson, M Vogelsang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 11, 2011
Noninvasive detection of graft rejection by in vivo (19) F MRI in the early stageU Flögel, S Su, I Kreideweiss, et al.
Deutsche Medizinische Wochenschrift (1946)|April 26, 2012
[Managing EHEC in hospital routine]B Ross, O Witzke, A Kribben, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2006
Repaglinide in the management of new-onset diabetes mellitus after renal transplantationT Türk, F Pietruck, S Dolff, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Transplantation Proceedings|March 17, 2007
Results of kidney transplantation with simultaneous implantation of vascular graftA Ozçelik, J Treckmann, A Paul, et al.
Clinical and Experimental Immunology|August 2, 2006
CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosusS Patschan, S Dolff, A Kribben, et al.
Scandinavian Journal of Immunology|October 21, 2016
Humoral and Cellular Responses to a Single Dose of Fendrix in Renal Transplant Recipients with Non-response to Previous Hepatitis B VaccinationM Lindemann, M Zaslavskaya, M Fiedler, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 22, 1999
Unique alterations of thyroid function parameters after i.v. administration of alkylating drugs (cyclophosphamide and ifosfamide)W Reinhardt, V Sauter, F Jockenhövel, et al.
Transplantation|August 15, 2001
Suppression mediated by anergic CD4+ T cells requires stimulation by MHC-peptide complexes and can be induced in the presence of costimulationO Witzke, P R Wheeler, J A Barbara, et al.
Annals of the Rheumatic Diseases|February 15, 2005
Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosisB M Spriewald, O Witzke, R Wassmuth, et al.
Clinical Pharmacology and Therapeutics|December 15, 2011
Plasma noradrenaline and state anxiety levels predict placebo response in learned immunosuppressionK Ober, S Benson, M Vogelsang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 11, 2011
Noninvasive detection of graft rejection by in vivo (19) F MRI in the early stageU Flögel, S Su, I Kreideweiss, et al.
Deutsche Medizinische Wochenschrift (1946)|April 26, 2012
[Managing EHEC in hospital routine]B Ross, O Witzke, A Kribben, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2006
Repaglinide in the management of new-onset diabetes mellitus after renal transplantationT Türk, F Pietruck, S Dolff, et al.
Pageof 9